title: Response to: Comment on: "Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis".
authors.affiliation: Department of Medicine, University of Cambridge, Cambridge, UK.
authors.forename: Kenneth Es
authors.initials: KE
authors.lastname: Poole
authors.affiliation: Department of Engineering, University of Cambridge, Cambridge, UK.
authors.forename: Graham M
authors.initials: GM
authors.lastname: Treece
authors.affiliation: Department of Engineering, University of Cambridge, Cambridge, UK.
authors.forename: Andrew H
authors.initials: AH
authors.lastname: Gee
authors.affiliation: CHU de Québec Research Centre (CRCHU), Laval University, Quebec City, Québec, Canada.
authors.forename: Jacques P
authors.initials: JP
authors.lastname: Brown
authors.affiliation: Oregon Osteoporosis Center, Portland, OR, USA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: McClung
authors.affiliation: Amgen Inc., Thousand Oaks, CA, USA.
authors.forename: Andrea
authors.initials: A
authors.lastname: Wang
authors.affiliation: Amgen Inc., Thousand Oaks, CA, USA.
authors.forename: Cesar
authors.initials: C
authors.lastname: Libanati
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D005272:Femur Neck; D006801:Humans; D015663:Osteoporosis, Postmenopausal
chemical_list: D061067:Antibodies, Monoclonal, Humanized